Onglyza Associated with Pancreatitis, Pancreatic Cancer, and Cardiac Issues
The Type 2 diabetes medication, Onglyza (saxagliptin), is often offered as a preferred option for diabetics, along with a healthy lifestyle, including exercise and diet; however, Onglyza has been associated with increased risks for pancreatic cancer and heart issues. Approved in 2009, Onglyza was released as a collaboration … [Read more...] about Onglyza Associated with Pancreatitis, Pancreatic Cancer, and Cardiac Issues
Plavix Lawsuits can Proceed in California, State Supreme Court Rules
In a recent decision, the California Supreme Court ruled that patients or their family members can sue drug maker Bristol-Myers Squibb for falsely advertising the benefits of the blood-thinning drug Plavix, although the company and most of the plaintiffs are based in other states. Plaintiffs in a number of class action lawsuits … [Read more...] about Plavix Lawsuits can Proceed in California, State Supreme Court Rules
New Mexico AG Files Lawsuit Against Plavix Manufacturers
The New Mexico Attorney General has filed a lawsuit against Bristol-Myers Squibb, the manufacturer of Plavix, alleging that the company failed to warn of risks associated with the blood thinner. The suit alleges that the pharmaceutical giant deceived New Mexicans by failing to warn about the increased risk of internal bleeding. The … [Read more...] about New Mexico AG Files Lawsuit Against Plavix Manufacturers
Coumadin Recalled by Bristol-Myers Squibb
Coumadin Are Being Recalled. Bristol-Myers Squibb, the maker of the blood thinner, Coumadin,has implemented a voluntary recall of three lots of physician sample blister packs of Coumadin® 1 mg tablets and five lots, of Coumadin 1 mg tablet hospital unit dose (HUD) blister packs, the U.S. Food and Drug Administration (FDA) … [Read more...] about Coumadin Recalled by Bristol-Myers Squibb
Bristol Myers Squibb to Pay $515M for Kickback
Bristol Myers Squibb to Pay $515 Million. Bristol Myers Squibb and its affiliate Apothecon, Inc. paid kickbacks to physicians for prescribing the company’s drugs and illegally promoted the off-label use of the anti-psychotic drug Abilify. Now, Bristol Myers Squibb has agreed to pay more than $500,000 to settle a civil … [Read more...] about Bristol Myers Squibb to Pay $515M for Kickback
Sustiva Use During Pregnancy May Cause Fetal Harm
Sustiva Use During Pregnancy. The U.S. Food and Drug Administration (FDA) and Bristol-Myers Squibb have warned healthcare professionals via letter against the use of efavirenz (Sustiva) during pregnancy due to the potential risk of fetal harm, especially during the first trimester, according to an alert sent last Friday from … [Read more...] about Sustiva Use During Pregnancy May Cause Fetal Harm
Bristol-Myers Squibb Reaches Settlement Over Breast Implants
87 Women Had Agreed to a Confidential Breast Implants Settlement. U.S. pharmaceutical maker Bristol-Myers Squibb Co. has reached an out of court settlement with a group of Australian women over faulty breast implants manufactured by the company, a court heard Tuesday. The New South Wales state Supreme Court was told that … [Read more...] about Bristol-Myers Squibb Reaches Settlement Over Breast Implants
